Why is Drug Induced Liver Injury an Important Mirror of Drug Safetyand How to Spot this early

Page 1

For Assistance Email: support@mentorhealth.com Phone: 800-447-9407 or

Fax your PO to: 302-288-6884

Live Webinar

on

Why is Drug Induced Liver Injury an Important Mirror of Drug Safety and How to Spot this early

Date & Time: Wednesday, November 30, 2011

10:00 AM PST | 01:00 PM EST

Duration: 90 Minutes

Instructor: Charles H Pierce

Location: Online

Price : $195.00

Instructor Profile: Charles H Pierce Consultant, Clinical Research / Drug-Device Development

Ferreting out which Investigational Medicinal Products (IMP) might cause significant liver injury is not an easy process partly because there is confusion about how to test for liver injury and part because these AEs are rare (in the 1:10,000+ area) or "idiosyncratic" in type so are not picked up in the usual drug development process testing. We all know that AE's are one of the key ways the Clinical Investigator has of monitoring the safety of subjects or patients in her/his charge but some are very rare so the Investigators must be 'heads-up'. Add to this, the large number of “non-drug liver injuries, which easily confound the issue. To be forewarned is forearmed.

Why you should attend: Whereas Drug Induced Liver Injury (DILI) is usually a rare event that is not found in the usually approval process, there are clues that all investigators and study staff must now. These will be reviewed in this Webinar.

Areas Covered in the Session:

l l l l

l

When is an abnormal lab value an AE? What are Liver Function Tests? Drug effects on the liver in perspective What are the risk and host factors for Drug Induced Liver Injury? Where does acetaminophen (Tylenol) toxicity fit in this

l

process? How and when do we detect "rare" events? What are the types of the liver's response to drugs?

l

How do 'non-drug liver injuries fit in the concept of DILI

l

Register Now

(for one

participant)

Overview:

Charles H. Pierce, MD, PhD, FCP, CPI is a consultant in the Clinical Research / Drug-Device Development arena specializing in bringing the message of GCP Regulations and Investigator Responsibility to the entire investigative team to help them understand the regulations as well as the ethics of research involving human subjects. Dr. Pierce serves as an advisor to several clinical research organizations, sits on industry based boards, and is VP of Medical Affairs for Harrison Clinical Research GmbH, a global CRO headquartered in Munich. ...more

Suggest a Topic

More Webinars

Your Necessity is our Priority

Click here to register for this webinar Who Will Benefit: l l

Principal Investigators and sub investigators Clinical Research Scientists

l

Safety Nurses Clinical Research Associates (CRAs) and Coordinators (CRCs) QA / QC auditors and staff

l

Clinical Research Data managers

l l

It would be really nice if you can circulate this mail to all your deserving colleagues who can immensely benefit from this program. For more information, please contact the event coordinator. We look forward to seeing you at the webinar. Best regards, Event-coordinator MentorHealth

About MentorHealth MentorHealth is a comprehensive training source for healthcare professionals. Our trainings are high on value, but not on cost. MentorHealth is the right training solution for healthcare professionals. With MentorHealth, healthcare professionals can make use of the best benefits relating to their professional training.


MentorHealth www.mentorhealth.com 1000 N West Street Suite, 1200 Wilmington DE 19801 Phone: 800-447-9407 or Fax your PO to: 302-288-6884 If you do not wish to receive this training alerts from GlobalCompliancePanel Click Unsubscribe


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.